Stratec SE (FRA:SBS)

Market Cap	264.39M
Revenue (ttm)	263.29M
Net Income (ttm)	15.53M
Shares Out	n/a
EPS (ttm)	1.28
PE Ratio	17.03
Forward PE	15.51
Dividend	0.60 (2.91%)
Ex-Dividend Date	Jun 30, 2025

Volume	30,096
Average Volume	1,672
Open	21.80
Previous Close	20.65
Day's Range	21.00 - 21.85
52-Week Range	20.00 - 36.90
Beta	n/a
RSI	34.07
Earnings Date	Nov 7, 2025

About Stratec SE

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1...

• Industry: Laboratory Analytical Instruments
• Founded: 1979
• Employees: 1,387
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SBS

Financial Performance

In 2024, Stratec SE's revenue was 257.62 million, a decrease of -4.73% compared to the previous year's 270.41 million. Earnings were 16.02 million, an increase of 4.24%.